These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1319736)
1. Binding of 111In-labeled HDL to platelets from normolipemic volunteers and patients with heterozygous familial hypercholesterolemia. Virgolini I; Li S; Yang Q; Banyai M; Koller E; Angelberger P; Sinzinger H Arterioscler Thromb; 1992 Jul; 12(7):849-61. PubMed ID: 1319736 [TBL] [Abstract][Full Text] [Related]
2. Binding of 111In-labeled LDL to platelets of normolipemic volunteers and patients with heterozygous familial hypercholesterolemia. Virgolini I; Li S; Qiong Y; Koller E; Banyai M; Angelberger P; Sinzinger H Arterioscler Thromb; 1993 Apr; 13(4):536-47. PubMed ID: 8466889 [TBL] [Abstract][Full Text] [Related]
3. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia. Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008 [TBL] [Abstract][Full Text] [Related]
4. Comparison of iodine-123 low-density lipoprotein (LDL) and indium-111 LDL binding to mononuclear cells of healthy normolipaemic controls and patients with heterozygous familial hypercholesterolaemia. Banyai M; Lupattelli G; Li SR; Pongratz S; Yang Q; Böck P; Angelberger P; Virgolini I Eur J Nucl Med; 1994 Jul; 21(7):634-9. PubMed ID: 7957349 [TBL] [Abstract][Full Text] [Related]
5. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations. Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444 [TBL] [Abstract][Full Text] [Related]
6. Discrimination between subclasses of human high-density lipoproteins by the HDL binding sites of bovine liver. Mendel CM; Kunitake ST; Kane JP Biochim Biophys Acta; 1986 Jan; 875(1):59-68. PubMed ID: 3000454 [TBL] [Abstract][Full Text] [Related]
7. Interaction of plasma lipoproteins with human platelets. Curtiss LK; Plow EF Blood; 1984 Aug; 64(2):365-74. PubMed ID: 6331546 [TBL] [Abstract][Full Text] [Related]
8. Abnormalities of high density lipoproteins in homozygous familial hypercholesterolemia. Goldberg RB; Fless GM; Baker SG; Joffe BI; Getz GS; Scanu AM; Seftel HC Arteriosclerosis; 1984; 4(5):472-8. PubMed ID: 6477298 [TBL] [Abstract][Full Text] [Related]
9. Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia. Inagaki M; Nakagawa-Toyama Y; Nishida M; Nakatani K; Nakaoka H; Kawase M; Kawase R; Tsubakio-Yamamoto K; Masuda D; Ohama T; Matsuyama A; Ishigami M; Komuro I; Yamashita S J Atheroscler Thromb; 2012; 19(7):643-56. PubMed ID: 22785024 [TBL] [Abstract][Full Text] [Related]
10. Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia. Tilly-Kiesi M; Tikkanen MJ J Lab Clin Med; 1992 Jul; 120(1):103-10. PubMed ID: 1613316 [TBL] [Abstract][Full Text] [Related]
11. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia. Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443 [TBL] [Abstract][Full Text] [Related]
12. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia. Guérin M; Dolphin PJ; Talussot C; Gardette J; Berthézène F; Chapman MJ Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1359-68. PubMed ID: 7670950 [TBL] [Abstract][Full Text] [Related]
13. Association of heterozygous familial hypercholesterolemia with smaller HDL particle size. Hogue JC; Lamarche B; Gaudet D; Tremblay AJ; Després JP; Bergeron J; Gagné C; Couture P Atherosclerosis; 2007 Feb; 190(2):429-35. PubMed ID: 16546193 [TBL] [Abstract][Full Text] [Related]
15. Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia. Frénais R; Maugeais C; Ouguerram K; Zaïr Y; Bard JM; Charbonnel B; Magot T; Krempf M Metabolism; 2001 Jun; 50(6):635-9. PubMed ID: 11398137 [TBL] [Abstract][Full Text] [Related]
16. Hepatic lipase activity and high density lipoproteins in familial hypercholesterolemia: adaptational mechanisms for LDL-receptor deficient state. Moriguchi EH; Tamachi H; Goto Y Tokai J Exp Clin Med; 1990 Nov; 15(6):401-6. PubMed ID: 1966695 [TBL] [Abstract][Full Text] [Related]
17. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia. Schrör K; Löbel P; Steinhagen-Thiessen E Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination. Leitersdorf E; Muratti EN; Eliav O; Meiner V; Eisenberg S; Dann EJ; Sehayek E; Peters TK; Stein Y Am J Med; 1994 May; 96(5):401-7. PubMed ID: 8192170 [TBL] [Abstract][Full Text] [Related]
19. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia. Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study. Christensen JJ; Ulven SM; Retterstøl K; Narverud I; Bogsrud MP; Henriksen T; Bollerslev J; Halvorsen B; Aukrust P; Holven KB Atherosclerosis; 2017 Nov; 266():48-57. PubMed ID: 28963918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]